Last reviewed · How we verify
NCT02044939
Pulmonary Rehabilitation in Patients With Sarcoidosis
NA trial testing Pulmonary rehabilitation program in Stage 4 Pulmonary Sarcoidosis in 38 participants. Completed in 6 July 2017.
6 July 2017
Quick facts
| Lead sponsor | University Hospital, Lille |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 38 |
| Start date | 10 July 2012 |
| Primary completion | 6 July 2017 |
| Estimated completion | 6 July 2017 |
| Sites | 11 locations across France |
Drugs / interventions tested
- Pulmonary rehabilitation program
Conditions studied
- Stage 4 Pulmonary Sarcoidosis — all drugs for Stage 4 Pulmonary Sarcoidosis →
Sponsor
University Hospital, Lille
Who can join
18 and older, any sex, with Stage 4 Pulmonary Sarcoidosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of the study is to assess the improvement of daily activity in subjects with Stage IV Pulmonary Sarcoidosis one year after the conduct of a pulmonary rehabilitation program. The secondary objectives are the following: * assess the improvement of daily activity at several times : 2, 6 and 12 months after the beginning of a pulmonary rehabilitation program * assess the improvement of exercise capacity by tests used in medical practice * assess the correlation between daily activity and exercise capacity * assess the improvement of dyspnea * assess the improvement of quality of life and psychological state
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Long-term effects of pulmonary rehabilitation on daily life physical activity of patients with stage IV sarcoidosis: A randomized controlled trial.
Wallaert B, Kyheng M, Labreuche J, Stelianides S, et al · · 2020 · cited 26× · PMID 31855785 · DOI 10.1016/j.resmer.2019.10.003 -
Daily life physical activity in patients with chronic stage IV sarcoidosis: A multicenter cohort study.
Froidure S, Kyheng M, Grosbois JM, Lhuissier F, et al · · 2019 · cited 15× · PMID 30809595 · DOI 10.1002/hsr2.109
Verify or expand the search:
- PubMed search for NCT02044939
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pulmonary rehabilitation program
Trials testing the same drug.
- NCT06847061 — Pulmonary Rehabilitation for Rural Patients With COPD · NA · recruiting
- NCT03477526 — Status and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary Rehabilitation · NA · terminated
- NCT03717012 — Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) · Phase 4 · terminated
- NCT03567772 — Videogame Assisted Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease · NA · completed
Other University Hospital, Lille trials
Trials by the same sponsor.
- NCT07528664 — Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking Duri · NA · not yet recruiting
- NCT07434739 — PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies · NA · not yet recruiting
- NCT06958224 — Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers · NA · not yet recruiting
- NCT07408999 — Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer · NA · not yet recruiting
- NCT07492030 — Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02044939 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Lille
- Last refreshed: 7 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02044939.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing